Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
- 2025-09
-
novel isoform identification br The follow up clinic These t
2019-05-13
The follow-up clinic These trial results have significant implications for clinic efficiencies. The safe and effective replacement of the bulk of “routine” in-clinic evaluations demonstrated in TRUST (Fig. 3) has a huge implication for resource utilization. Although demanding adjustment to differ
-
However it should be noted that
2019-05-13
However, it should be noted that large proportion of patients develop at least one SRE after BTAs purchase Tunicamycin (74/155, 48%) appearing to be in keeping with the results of randomised BTA trials [3–6]. Indeed, for those patients who had not had an SRE prior to commencing a BTA, their risk of
-
Macrophages in bone metastasis main outstanding questions br
2019-05-13
Macrophages in bone metastasis – main outstanding questions: Conflict of interest statement Acknowledgements IV was supported by a generous grant from Weston Park Hospital Cancer Charity, Sheffield, UK. Introduction In recent years there has been increasing interest in the role of bone-ta
-
Two studies are ongoing that promise to be paramount in
2019-05-13
Two studies are ongoing that promise to be paramount in the prescription of dexamethasone in the prophylaxis of pain flare. NCIC CTG is currently investigating the use of 8mg dexamethasone daily on the day of treatment and four days post-treatment versus placebo of the same duration (NCT01248585) [1
-
Despite potassium administration her serum potassium concent
2019-05-13
Despite potassium administration, her serum potassium concentration did not normalize until 56h after admission because she naloxone hydrochloride had taken hydrocortisone for pituitary adrenal insufficiency after surgery for a pituitary tumor. Under the persistent hypokalemic condition (K+=2.5–2.64
-
Study Design br Discussion Debate persists about how to best
2019-05-13
Discussion Debate persists about how to best define the ER ECG pattern. There is consensus regarding definition of the malignant form of ER as a J-point elevation that could be (or not) associated with ST elevation [1]. In this case, a clear J-point elevation was seen, particularly in lead III (F
-
In silico prediction software SIFT PolyPhen CADD and other p
2019-05-13
In silico prediction software, SIFT [51], PolyPhen2 [52], CADD [53], and other prediction systems are useful to evaluate a specific mutation which is detected in a patient. However, even if the in silico software predicts a mutation as pathogenic, we need to examine whether the genetic result is com
-
chemicals the full details Concurrent with the clinical eval
2019-05-13
Concurrent with the clinical evaluation of the family, the genetic findings from a molecular autopsy may help to elucidate the cause of death in the decedent, as well as provide a basis for cascade genetic testing of at-risk family members. Offering cascade genetic testing to asymptomatic relatives
-
The aim of this cross sectional
2019-05-13
The aim of this cross-sectional study was to investigate the relationships between patient characteristics and antithrombotic therapy prescribed for the prevention of ischemic stroke and systemic embolism in patients with NVAF in clinical practice. Additionally, because the data were to be used to c
-
In an earlier study we used a
2019-05-13
In an earlier study, we used a questionnaire to assess musculoskeletal pain in patients with CML who had achieved DMR (MR4.0) and discontinued TKI treatment, including IM, nilotinib, and dasatinib [5]. Nine out of the 27 patients surveyed developed musculoskeletal pain after discontinuing TKIs. In t
-
India s National Programme for Prevention and Control
2019-05-13
India\'s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke is an important step to integrate preventative and treatment interventions within the National Health Mission Framework. Reliable, direct monitoring of cause-specific mortality in India is s
-
The circadian variation of VF shows a
2019-05-10
The circadian variation of VF shows a similar nocturnal pattern in patients with BS and ERS [32] (Fig. 2). This is in contrast to the circadian pattern of VTAs in patients with ischemic heart diseases [33]. In a Korean cohort of patients with ERS and BS who underwent implantable cardioverter defibr
-
After exclusion of secondary causes of
2019-05-10
After exclusion of secondary causes of eosinophilia, diagnostic evaluation of primary eosinophilias relies on a combination of morphologic review of the blood and marrow, standard cytogenetics, fluorescent in situ hybridization, flow immunocytometry, and T-cell clonality assessment to detect histopa
-
h2 receptor antagonist Causative genes for ARVC and their re
2019-05-10
Causative genes for ARVC and their respective characteristics are summarized in Table 1. Desmosome genes for ARVC Other causative genes for ARVC Although more than half of ARVC patients carry mutations in desmosome genes, other genes have also been reported as causative genes for ARVC (Table
-
Confrontaremos los datos que la hemerograf a nos ofrece
2019-05-10
Confrontaremos los datos que la hemerografía nos ofrece y las fuentes orales que han permitido la reconstrucción y el conocimiento de la experiencia del -. A partir de ello, queremos contribuir en el discernimiento y reconstrucción del conflicto, el cual, hematoxylin 20 años de la firma de los Acuer
16424 records 1060/1095 page Previous Next First page 上5页 10561057105810591060 下5页 Last page